Published in J Pediatr on May 01, 1990
Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed (1999) 1.49
Lipid peroxidation as a measure of oxygen free radical damage in the very low birthweight infant. Arch Dis Child Fetal Neonatal Ed (1994) 1.25
High plasma vitamin C concentrations at birth associated with low antioxidant status and poor outcome in premature infants. Arch Dis Child Fetal Neonatal Ed (1994) 0.99
Suppressive effects of breast milk on oxidative DNA damage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed (2004) 0.98
Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies. Arch Dis Child Fetal Neonatal Ed (2004) 0.93
Maternal and fetal indicators of oxidative stress in various obstetric complications. Indian J Clin Biochem (2003) 0.88
Breath pentane as a marker for lipid peroxidation and adverse outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed (1998) 0.88
Resuscitation of preterm infants with reduced oxygen results in less oxidative stress than resuscitation with 100% oxygen. J Clin Biochem Nutr (2008) 0.86
Antioxidants in neonatal lung disease. Arch Dis Child Fetal Neonatal Ed (1995) 0.79
Maternal and fetal indicators of oxidative stress during intrauterine growth retardation (IUGR). Indian J Clin Biochem (2006) 0.76
Adduct of malondialdehyde to hemoglobin: a new marker of oxidative stress that is associated with significant morbidity in preterm infants. Oxid Med Cell Longev (2013) 0.76
Parenteral lipids and free radicals in preterm infants. Arch Dis Child (1992) 0.75
Breath pentane as a potential biomarker for survival in hepatic ischemia and reperfusion injury--a pilot study. PLoS One (2012) 0.75
Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr (1985) 1.92
Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest (1983) 1.83
Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest (1982) 1.76
Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity. Am J Obstet Gynecol (1976) 1.66
Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J Pediatr (1991) 1.59
Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol (1989) 1.58
Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr (1994) 1.52
Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth. Acta Paediatr (2003) 1.49
Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity. J Clin Invest (1988) 1.44
Variable oxygenation response to inhaled nitric oxide in severe persistent pulmonary hypertension of the newborn. Acta Paediatr (1995) 1.40
Respiratory distress syndrome treated with human surfactant: radiographic findings. Radiology (1985) 1.39
Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns. Pediatr Res (1977) 1.27
Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome. Pediatrics (1983) 1.27
Prophylactic treatment of very premature infants with human surfactant. N Engl J Med (1986) 1.27
Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage. J Clin Invest (1981) 1.25
Effects of antenatal endotoxin and glucocorticoids on the lungs of preterm lambs. Am J Obstet Gynecol (2000) 1.21
Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest (1997) 1.12
Ontogeny of Toll-like receptors Tlr2 and Tlr4 in mice. Pediatr Res (2001) 1.12
Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. Am J Hum Genet (2000) 1.11
Changes in mitochondrial respiratory chain proteins during perinatal development. Evidence of the importance of environmental oxygen tension. Biochim Biophys Acta (1971) 1.10
Phosphatidylglycerol in lung surfactant. III. Possible modifier of surfactant function. J Lipid Res (1976) 1.08
Neurodevelopmental and respiratory outcome in early childhood after human surfactant treatment. Am J Dis Child (1988) 1.06
Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet (2000) 1.05
The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome. Am J Respir Crit Care Med (1996) 1.03
Changing incidence and outcome of infants with respiratory distress syndrome in the 1990s: a population-based survey. Acta Paediatr (2004) 1.01
Recombinant human erythropoietin: possible role as an antioxidant in premature rabbits. Pediatr Res (1996) 1.01
The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatr Res (1991) 1.01
Generation of free radicals in lipid emulsion used in parenteral nutrition. Pediatr Res (1991) 1.00
Development of the fetal lung. J Perinat Med (1977) 0.99
Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics (1994) 0.99
Surfactant protein-A gene locus associated with recurrent otitis media. J Pediatr (2001) 0.98
Formation of acidic phospholipids in rabbit lung during perinatal development. Pediatr Res (1980) 0.96
Transforming growth factor-beta 2 prevents preterm delivery induced by interleukin-1 alpha and tumor necrosis factor-alpha in the rabbit. Am J Obstet Gynecol (1993) 0.95
Inhaled nitric oxide decreases hyperoxia-induced surfactant abnormality in preterm rabbits. Pediatr Res (1999) 0.95
Bruton's tyrosine kinase together with PI 3-kinase are part of Toll-like receptor 2 multiprotein complex and mediate LTA induced Toll-like receptor 2 responses in macrophages. Cell Signal (2006) 0.93
Comparison of four surfactants: in vitro surface properties and responses of preterm lambs to treatment at birth. Pediatrics (1987) 0.92
Lung profile: sex differences in normal pregnancy. Obstet Gynecol (1985) 0.92
Role of myo-inositol in the synthesis of phosphatidylglycerol and phosphatidylinositol in the lung. Biochem Biophys Res Commun (1980) 0.91
Respiratory distress syndrome and inositol supplementation in preterm infants. Arch Dis Child (1986) 0.91
Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res (1986) 0.91
Perinatal development of myoinositol uptake into lung cells: surfactant phosphatidylglycerol and phosphatidylinositol synthesis in the rabbit. Pediatr Res (1986) 0.90
Phosphatidylglycerol in lung surfactant. II. Subcellular distribution and mechanism of biosynthesis in vitro. Biochim Biophys Acta (1975) 0.90
Surfactant-anti-surfactant immune complexes in infants with respiratory distress syndrome. Am J Pathol (1986) 0.89
Measurement of the lecithin/sphingomyelin ratio and phosphatidylglycerol in aminotic fluid: an accurate method for the assessment of fetal lung maturity. Br J Obstet Gynaecol (1981) 0.89
The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Am J Obstet Gynecol (1991) 0.89
Reconstitution of surfactant activity using purified human apoprotein and phospholipids measured in vitro and in vivo. Am Rev Respir Dis (1986) 0.89
Role of myoinositol in regulation of surfactant phospholipids in the newborn. Early Hum Dev (1985) 0.87
Regulation of tyrosine aminotransferase in foetal rat liver. Biochem J (1980) 0.87
Immaturity-dependent free radical activity in premature infants. Pediatr Res (1994) 0.87
Purification and properties of human liver tyrosine aminotransferase. Clin Chim Acta (1982) 0.87
Isolated lamellar bodies from rat lung: correlated ultrastructural and biochemical studies. Lab Invest (1976) 0.87
Intravascular ultrasound characterization of thrombi of different composition. Am J Cardiol (1994) 0.86
Expression and localization of lung surfactant protein B in Eustachian tube epithelium. Am J Physiol Lung Cell Mol Physiol (2001) 0.86
Immunologic consequences of exogenous surfactant administration. Semin Perinatol (1988) 0.86
Hypoxanthine and oxygen induced lung injury: a possible basic mechanism of tissue damage? Pediatr Res (1984) 0.85
Myoinositol in small preterm infants: relationship between intake and serum concentration. J Pediatr Gastroenterol Nutr (1986) 0.85
Cardiolipin and cytochrome AA 3 in intact liver mitochondria of rats. Evidence of successive formation of inner membrane components. Biochem Biophys Res Commun (1971) 0.85
Inositol supplementation in respiratory distress syndrome: relationship between serum concentration, renal excretion, and lung effluent phospholipids. J Pediatr (1987) 0.85
Degree of lung maturity determines the direction of the interleukin-1- induced effect on the expression of surfactant proteins. Am J Respir Cell Mol Biol (2000) 0.84
Is there a brain tyrosine aminotransferase? Biochem J (1982) 0.84
Tyrosine aminotransferase activity in human fetal liver. J Dev Physiol (1981) 0.84
Two-year follow-up of a randomised trial with repeated antenatal betamethasone. Arch Dis Child Fetal Neonatal Ed (2009) 0.84
A prospective randomized study of 1- and 2-stage sinus inlay bone grafts: 1-year follow-up. Int J Oral Maxillofac Implants (2000) 0.84
Value of absent or retrograde end-diastolic flow in fetal aorta and umbilical artery as a predictor of perinatal outcome in pregnancy-induced hypertension. Acta Paediatr (1993) 0.84
Glycolipid accumulation in bronchoalveolar space in adult respiratory distress syndrome. J Lipid Res (1984) 0.84
Health and the use of health care services in 5-year-old very-low-birth-weight infants. Acta Paediatr (2010) 0.83
Induction of cytosolic tyrosine aminotransferase by dexamethasone in organ culture of fetal human liver. Early Hum Dev (1982) 0.83
Respiratory distress syndrome: evaluation of genetic susceptibility and protection by transmission disequilibrium test. Hum Genet (2001) 0.83
Blood glucose level in preterm infants after antenatal exposure to glucocorticoid. Acta Paediatr (2007) 0.83
Determination of ethane and pentane in free oxygen radical-induced lipid peroxidation. Lipids (1989) 0.83
Influence of fetal gender on the concentration of interleukin-1 receptor antagonist in amniotic fluid and in newborn urine. Pediatr Res (1994) 0.83
Comparison of the effects of disulfiram and dimercaptopropanol arsenite on mitochondrial structure and function. Biochem Pharmacol (1967) 0.83
Phosphatidyl glycerol in lung surfactant. 1. Synthesis in rat lung microsomes. Biochem Biophys Res Commun (1974) 0.83
Interleukin-1 receptor antagonist in the fetomaternal compartment. Acta Paediatr (1995) 0.83
Composition and surface activity of normal and phosphatidylglycerol-deficient lung surfactant. Pediatr Res (1985) 0.83
Surfactant protein A and D expression in the porcine Eustachian tube. FEBS Lett (1999) 0.82
Human surfactant treatment of severe respiratory distress syndrome: pulmonary effluent indicators of lung inflammation. J Pediatr (1986) 0.82
Surfactant proteins A and D in Eustachian tube epithelium. Am J Physiol Lung Cell Mol Physiol (2001) 0.82
Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens. Pediatr Res (1994) 0.82
Immunomodulation by pulmonary surfactant. J Lab Clin Med (1988) 0.82
Human surfactant: a therapeutic trial in premature rabbits. J Pediatr (1982) 0.81
Human surfactant protein--A gene locus for genetic studies in the Finnish population. Dis Markers (2000) 0.81
Post-traumatic bone mineral loss in tibial shaft fractures treated with a weight-bearing brace. Acta Orthop Scand (1979) 0.81
Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant. J Pediatr (1993) 0.81
Antigenicity of low molecular weight surfactant species. Am J Pathol (1989) 0.80
Immediate effects on lung function of instilled human surfactant in mechanically ventilated newborn infants with IRDS. Acta Paediatr Scand (1990) 0.80
Purification of a hydrophobic surfactant peptide using high-performance liquid chromatography. Anal Biochem (1988) 0.80
The effect of betamethasone and fetal sex on the synthesis and maturation of lung surfactant phospholipids in rabbits. Biochim Biophys Acta (1983) 0.80
Immunogenicity of surfactant. I. Human alveolar surfactant. Clin Exp Immunol (1991) 0.80
Immunogenicity of surfactant. II. Porcine and bovine surfactants. Clin Exp Immunol (1991) 0.80
Diminished inducible nitric oxide synthase expression in fulminant early-onset neonatal pneumonia. Pediatrics (2000) 0.80
Myoinositol decreases N-nitroso-N-methylurethane induced lung surfactant deficiency. Life Sci (1982) 0.80
Perinatal development of inositol synthesis and catabolism in rabbit kidney. Biol Neonate (1991) 0.80
Free-radical-induced lipid peroxidation during the early neonatal period. Acta Paediatr (1994) 0.80
Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome. Drugs (1989) 0.79
Premature rupture of the membranes: effect of penicillin prophylaxis and long-term outcome of the children. Am J Perinatol (1992) 0.79
Respiratory distress syndrome--update 1982. Pediatr Clin North Am (1982) 0.79
Surfactant abnormality after endotoxin-induced lung injury in guinea-pigs. Eur J Respir Dis (1987) 0.79